2019 Lung Cancer Fall Preview

2019 Lung Cancer Fall Preview

Episodes

Specialty:

All

Year:

All

EP. 1: Overview of Novel Therapy for Advanced-Stage NSCLC

September 6th 2019

EP. 2: Advanced-Stage NSCLC: Overall Survival Data From FLAURA

September 6th 2019

EP. 3: LIBRETTO-001: Targeting RET Fusions in Advanced-Stage NSCLC

September 6th 2019

EP. 4: Updated Data in Stage IV NSCLC: CheckMate-227

September 6th 2019

EP. 5: Metastatic NSCLC: Interpreting Data From NEPTUNE

September 6th 2019

EP. 6: Future Directions in Lung Cancer Management

September 6th 2019

EP. 7: Targeted Therapy for KRAS p.G12C NSCLC

September 6th 2019

EP. 8: Extensive-Stage SCLC: Potential in the CASPIAN Trial

September 6th 2019

EP. 9: Expanding the NSCLC Armamentarium: IMpower131

September 6th 2019

EP. 10: MET as a Clinical Target in Lung Cancer

September 6th 2019

EP. 11: Novel Lung Cancer Therapy: Future Improvements and Challenges

September 6th 2019

Trending on OncLive

DESTINY-Lung04 Showcases PFS Benefit With First-Line T-DXd in HER2-Mutant NSCLC

Adjuvant Osimertinib Keeps OS Benefit at 8 Years in Resected EGFR-Mutated Stage IB to IIIA NSCLC

Intercalated Gefitinib Plus Chemotherapy Improves DFS in Resected EGFR-Mutant NSCLC

PAPILLON: Frontline Amivantamab Plus Chemotherapy Yields 34.3-Month Median OS in EGFR Exon 20 Insertion–Positive NSCLC

Zidesamtinib Yields High Response Rates in TKI-Naive Advanced ROS1+ NSCLC